Headshot of John W. Krakauer.

John W. Krakauer

Director of the Centre for Restorative Neurotechnology, Champalimaud Foundation
Professor of neurology, Johns Hopkins University

John Krakauer is director of the Centre for Restorative Neurotechnology at the Champalimaud Foundation and John C. Malone professor of neurology, neuroscience, and physical medicine and rehabilitation at Johns Hopkins University. He is also an external professor at the Santa Fe Institute. Krakauer is a world leader in motor control and stroke recovery, and his work bridges the gap between basic neuroscience, creative engineering and the philosophy of mind. At the Champalimaud Foundation, he leads the “software as medicine” initiative, using immersive animation, generative artificial intelligence and digital neurotherapeutics to treat chronic neurological and psychiatric conditions. 

He is co-inventor of the “MindPod Dolphin,” an FDA-listed neuro-rehabilitation technology licensed to MindMaze. He is also the author of “Broken Movement: The Neurobiology of Motor Recovery after Stroke” (MIT Press) and is currently writing a new book on the nature of intelligence for Princeton University Press. His research and unique approach to “exergaming” for brain health have been profiled in The New Yorker, The Atlantic and The New York Times.

Explore more from The Transmitter

Mouse cortical organoid.

Hasty stem cells highlight potential limitation with cortical organoids

The models recapitulate many key developmental processes, but some radial glial cells in mouse organoids make neurons earlier than they should.

By Giorgia Guglielmi
22 September 2026 | 4 min read
Illustration of an open journal featuring lines of text and small illustrations of eyes and mouths.

Two populations of neurons, two effects on sociability; and more

Here is a roundup of autism-related news and research spotted around the web for the week of 21 September.

By Jill Adams
22 September 2026 | 2 min read

Finding the Rett syndrome gene and ways to fix it

Kevin Mitchell talks with Huda Zoghbi about her work identifying the MECP2 gene, its role in the brain and therapies to address its dysfunction.

By Kevin Mitchell
21 September 2026 | 4 min read